Ask AI
SAVANNAH Randomized Subset
SAVANNAH Subset: Savolitinib ± Osimertinib for Advanced EGFRm NSCLC With MET Amplification or Overexpression After Progressing on Osimertinib

Released: June 04, 2025

Expiration: December 03, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 04, 2025

Expiration: December 03, 2025